Endothelial Cell Death Induced by Tumor Necrosis Factor-α Is Inhibited by the Bcl-2 Family Member, A1*

Endothelial cells play a central role in the inflammatory process. Tumor necrosis factor-α (TNF) is a multifunctional cytokine which elicits many of the inflammatory responses of endothelial cells. While TNF directly causes apoptosis of tumor cells and virally infected cells, normal cells are generally resistant. However, most resistant cells, including human endothelial cells, can be rendered susceptible to TNF by inhibiting RNA or protein synthesis. This finding suggests that TNF provides a cell survival signal in addition to a death signal. We have previously cloned a human Bcl-2 homologue, A1, and shown that it is specifically induced by proinflammatory cytokines but not by endothelial growth factors. In this study, we show that retroviral-mediated transfer of the A1 cDNA to a human microvascular endothelial cell line provides protection against cell death initiated by TNF in the presence of actinomycin D. The induction of A1 by TNF in this system is mediated via a protein kinase C pathway. Since TNF signaling has also been shown to proceed via ceramides, we tested whether exogenous ceramides could induce A1. Our findings indicate that ceramides do not induce A1 but do up-regulate c-jun and induce endothelial death. Ceramide-activated endothelial death is also inhibited by A1, suggesting that TNF may initiate divergent survival and death pathways via separate lipid second messengers.

[1]  David Wallach,et al.  Involvement of MACH, a Novel MORT1/FADD-Interacting Protease, in Fas/APO-1- and TNF Receptor–Induced Cell Death , 1996, Cell.

[2]  Matthias Mann,et al.  FLICE, A Novel FADD-Homologous ICE/CED-3–like Protease, Is Recruited to the CD95 (Fas/APO-1) Death-Inducing Signaling Complex , 1996, Cell.

[3]  V. Modur,et al.  Endothelial Cell Inflammatory Responses to Tumor Necrosis Factor α , 1996, The Journal of Biological Chemistry.

[4]  C. Borner,et al.  Bcl-2 interrupts the ceramide-mediated pathway of cell death. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[5]  Y. Hannun,et al.  prICE: a downstream target for ceramide-induced apoptosis and for the inhibitory action of Bcl-2. , 1996, The Biochemical journal.

[6]  S. Hakomori,et al.  Regulatory role of ceramide in interleukin (IL)-1 beta-induced E-selectin expression in human umbilical vein endothelial cells. Ceramide enhances IL-1 beta action, but is not sufficient for E-selectin expression. , 1996, The Journal of biological chemistry.

[7]  A. Karsan,et al.  Cloning of human Bcl-2 homologue: inflammatory cytokines induce human A1 in cultured endothelial cells. , 1996, Blood.

[8]  L. Zon,et al.  Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis , 1996, Nature.

[9]  A. Chinnaiyan,et al.  FADD/MORT1 Is a Common Mediator of CD95 (Fas/APO-1) and Tumor Necrosis Factor Receptor-induced Apoptosis (*) , 1996, The Journal of Biological Chemistry.

[10]  John Calvin Reed,et al.  A1, a Bcl-2 family member, prolongs cell survival and permits myeloid differentiation. , 1996, Blood.

[11]  Hong-Bing Shu,et al.  TRADD–TRAF2 and TRADD–FADD Interactions Define Two Distinct TNF Receptor 1 Signal Transduction Pathways , 1996, Cell.

[12]  J. Dickinson,et al.  Plasminogen Activator Inhibitor Type 2 Inhibits Tumor Necrosis Factor α-induced Apoptosis , 1995, The Journal of Biological Chemistry.

[13]  H. Umehara,et al.  Requirement of AP-1 for Ceramide-induced Apoptosis in Human Leukemia HL-60 Cells (*) , 1995, The Journal of Biological Chemistry.

[14]  D. Brenner,et al.  Ceramide Activates the Stress-activated Protein Kinases (*) , 1995, The Journal of Biological Chemistry.

[15]  K. Scotto,et al.  Ceramide synthase mediates daunorubicin-induced apoptosis: An alternative mechanism for generating death signals , 1995, Cell.

[16]  T. Behrens,et al.  Bcl-xL rescues WEHI 231 B lymphocytes from oxidant-mediated death following diverse apoptotic stimuli. , 1995, Journal of immunology.

[17]  V. Dixit,et al.  Bcl-x and Bcl-2 inhibit TNF and Fas-induced apoptosis and activation of phospholipase A2 in breast carcinoma cells. , 1995, Oncogene.

[18]  Z. Fuks,et al.  Ceramide: a signal for apoptosis or mitogenesis? , 1995, The Journal of experimental medicine.

[19]  T. Mak,et al.  CD28 signals through acidic sphingomyelinase , 1995, The Journal of experimental medicine.

[20]  Arul M. Chinnaiyan,et al.  FADD, a novel death domain-containing protein, interacts with the death domain of fas and initiates apoptosis , 1995, Cell.

[21]  D. Goeddel,et al.  The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation , 1995, Cell.

[22]  J. Camonis,et al.  A Novel Protein That Interacts with the Death Domain of Fas/APO1 Contains a Sequence Motif Related to the Death Domain (*) , 1995, The Journal of Biological Chemistry.

[23]  S. Grant,et al.  Attenuation of ceramide-induced apoptosis by diglyceride in human myeloid leukemia cells. , 1994, The Journal of biological chemistry.

[24]  M. Krönke,et al.  The role of diacylglycerol and ceramide in tumor necrosis factor and interleukin‐1 signal transduction , 1994, Journal of leukocyte biology.

[25]  A. Haimovitz-Friedman,et al.  Ionizing radiation acts on cellular membranes to generate ceramide and initiate apoptosis , 1994, The Journal of experimental medicine.

[26]  L. Sanz,et al.  Protein kinase C zeta isoform is critical for kappa B-dependent promoter activation by sphingomyelinase. , 1994, The Journal of biological chemistry.

[27]  J. Michaeli,et al.  Protein kinase C mediates basic fibroblast growth factor protection of endothelial cells against radiation-induced apoptosis. , 1994, Cancer research.

[28]  S. Grant,et al.  Induction of apoptotic DNA damage and cell death by activation of the sphingomyelin pathway. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[29]  John Calvin Reed Bcl-2 and the regulation of programmed cell death , 1994, The Journal of cell biology.

[30]  C. Thompson,et al.  bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death , 1993, Cell.

[31]  W. Fiers,et al.  Effect of bcl-2 proto-oncogene expression on cellular sensitivity to tumor necrosis factor-mediated cytotoxicity. , 1993, Oncogene.

[32]  Y. Hannun,et al.  Programmed cell death induced by ceramide. , 1993, Science.

[33]  T. Hennet,et al.  Expression of BCL-2 protein enhances the survival of mouse fibrosarcoid cells in tumor necrosis factor-mediated cytotoxicity. , 1993, Cancer research.

[34]  R. Swerlick,et al.  HMEC-1: establishment of an immortalized human microvascular endothelial cell line. , 1992, The Journal of investigative dermatology.

[35]  V. Dixit,et al.  The A20 zinc finger protein protects cells from tumor necrosis factor cytotoxicity. , 1992, The Journal of biological chemistry.

[36]  C. Baglioni,et al.  Protection from tumor necrosis factor-mediated cytolysis by overexpression of plasminogen activator inhibitor type-2. , 1991, The Journal of biological chemistry.

[37]  R. Cotran,et al.  The role of endothelial cells in inflammation. , 1990, Transplantation.

[38]  Y. Shimada,et al.  Apoptosis of vascular endothelial cells by fibroblast growth factor deprivation. , 1990, Biochemical and biophysical research communications.

[39]  R. Cotran,et al.  Cytokines and endothelial cell biology. , 1990, Physiological reviews.

[40]  Miller Ad,et al.  Improved Retroviral Vectors for Gene Transfer and Expression , 1989 .

[41]  G. Wong,et al.  Manganous superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor , 1989, Cell.

[42]  T. Pohlman,et al.  Human endothelial cell response to lipopolysaccharide, interleukin-1, and tumor necrosis factor is regulated by protein synthesis. , 1989, Cellular immunology.

[43]  J. Minna,et al.  Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of radiosensitivity. , 1987, Cancer research.

[44]  B. Aggarwal,et al.  Recombinant human tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitro. , 1985, Science.

[45]  D. Wallach Preparations of lymphotoxin induce resistance to their own cytotoxic effect. , 1984, Journal of immunology.

[46]  T. Maciag,et al.  An endothelial cell growth factor from bovine hypothalamus: identification and partial characterization. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[47]  R L Kassel,et al.  An endotoxin-induced serum factor that causes necrosis of tumors. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[48]  Daniel G. Miller,et al.  Use of retroviral vectors for gene transfer and expression. , 1993, Methods in enzymology.

[49]  H. Wepsic,et al.  The effects of protein kinase inhibitors on lymphocyte blastogenesis and GVHD-induced splenomegaly. , 1989, Immunopharmacology and immunotoxicology.

[50]  D. Wallach Cytotoxins (tumour necrosis factor, lymphotoxin and others): molecular and functional characteristics and interactions with interferons. , 1986, Interferon.